Healthcare provider profile · identity verified

Jeffrey B Andersen, MD

Family Practice · FARGO, ND · NPI 1184701856

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	562	168
Losartan Potassium	Losartan Potassium	308	87
Lisinopril	Lisinopril	303	94
Amlodipine Besylate	Amlodipine Besylate	280	92
Rosuvastatin Calcium	Rosuvastatin Calcium	269	80
Omeprazole	Omeprazole	238	74
Tamsulosin Hcl	Tamsulosin Hcl	209	68
Metoprolol Succinate	Metoprolol Succinate	204	66
Gabapentin	Gabapentin	195	43
Simvastatin	Simvastatin	195	62
Metformin Hcl	Metformin Hcl	183	57
Levothyroxine Sodium	Levothyroxine Sodium	168	50
Hydrochlorothiazide	Hydrochlorothiazide	166	49
Ozempic	Semaglutide	162	34
Pantoprazole Sodium	Pantoprazole Sodium	161	37
Metoprolol Tartrate	Metoprolol Tartrate	137	38
Metformin Hcl Er	Metformin Hcl	128	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	122	43
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	108	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	107	31
Furosemide	Furosemide	96	29
Bupropion Xl	Bupropion Hcl	92	17
Allopurinol	Allopurinol	87	24
Sertraline Hcl	Sertraline Hcl	86	28
Albuterol Sulfate Hfa	Albuterol Sulfate	83	32
Duloxetine Hcl	Duloxetine Hcl	82	23
Carvedilol	Carvedilol	80	23
Pravastatin Sodium	Pravastatin Sodium	70	21
Finasteride	Finasteride	67	23
Montelukast Sodium	Montelukast Sodium	66	15
Trazodone Hcl	Trazodone Hcl	65	19
Escitalopram Oxalate	Escitalopram Oxalate	64	21
Lorazepam	Lorazepam	64	20
Warfarin Sodium	Warfarin Sodium	64	19
Fluticasone Propionate	Fluticasone Propionate	61	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	16
Meloxicam	Meloxicam	58	17
Oxycodone Hcl	Oxycodone Hcl	57	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	57	14
Famotidine	Famotidine	52	11
Eliquis	Apixaban	51	12
Potassium Chloride	Potassium Chloride	51	15
Fluoxetine Hcl	Fluoxetine Hcl	50	14
Jardiance	Empagliflozin	48	11
Tramadol Hcl	Tramadol Hcl	47	14
Clopidogrel	Clopidogrel Bisulfate	45	15
Glipizide	Glipizide	43	15
Diclofenac Sodium	Diclofenac Sodium	41	suppressed
Pregabalin	Pregabalin	40	suppressed
Glipizide Er	Glipizide	39	13
Mounjaro	Tirzepatide	39	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Atenolol	Atenolol	32	12
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Baclofen	Baclofen	29	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	14
Celecoxib	Celecoxib	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Prazosin Hcl	Prazosin Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Prednisone	Prednisone	25	13
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Topiramate	Topiramate	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Naproxen	Naproxen	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amoxicillin	Amoxicillin	12	11
Benazepril Hcl	Benazepril Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error